Drug of Abuse (DOA)
Opiates (OPI) Rapid Test
Detects Opiates. colloidal-gold. Specimen: Urine.
| Target / Analyte | Opiates |
|---|---|
| Disease / Indication | Drug screening |
| Series | Drug of Abuse (DOA) |
| Method | colloidal-gold |
| Specimen | Urine |
| Regulatory | CE |
| OEM/ODM | Available — private label & custom panel |
Direct Answer
This rapid test detects Opiates in Urine to support Drug screening. It is a colloidal-gold screening test — a reactive result is presumptive and should be confirmed per the intended use.
Intended Use
Detection of opiates in urine.
Clinical Context
Opiate-class screening; cut-off 2000 ng/mL.
Test Principle
Colloidal-gold immunochromatography (lateral flow). The device captures the target analyte (antigen or antibody) on a membrane via labeled antibodies, producing a visible test line within minutes. Qualitative or semi-quantitative, intended as a screening/triage aid — not a replacement for confirmatory laboratory testing.
Limitations
Class-level test — confirm specific opiate by lab method.
Procurement
Specimen: urine. Format: cassette / dipstick / panel. CE-marked line.
Interpretation
| Result | Lines | Meaning |
|---|---|---|
| Positive | Test + control line | Target detected (presumptive positive) |
| Negative | Control line only | Below cut-off / not detected |
| Invalid | No control line | Repeat with a new device |
Available SKUs (this series)
| Cat. No. | Product | Specimen | Format | Kit Size | Status |
|---|---|---|---|---|---|
| DOP-102 | Opiates (OPI) Rapid Test Cassette | Urine | Cassette | 40 T | CE/FDA |
| DOP-114 | Opiates (OPI) Rapid Test Panel | Urine | Panel | 40 T | CE/FDA |
| DOP-101 | Opiates (OPI) Rapid Test Dipstick | Urine | Dipstick | 50 T | CE/FDA |
| DOP-802 | Opiates (OPI) Rapid Test Cassette | Oral Fluid | Cassette | 25 T | CE |
| DOP-803 | Opiates (OPI) Rapid Test Midstream | Oral Fluid | Midstream | 25 T | CE |
Documentation & quotation — datasheet, IFU, MOQ and OEM/ODM options on request.
Last reviewed: 2026-09-12